FDA Approves Florida’s Application to Import Drugs from Canada

Start
On January 5, 2024, the Food and Drug Administration (FDA) authorized the state of Florida’s proposal under the Section 804 Importation Program (SIP) for a period of two years. FDA’s action marks the first time a state drug importation program has been authorized pursuant to the 2020 final rule implementing the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA)….
By: Manatt, Phelps & Phillips, LLP
Previous Story

Cross-Border Transfer of Evidence from Mainland China under International Commercial Dispute Resolution Scenarios

Next Story

Middle District of North Carolina Grants Preliminary Injunction in Natera, Inc. v. NeoGenomics Laboratories, Inc.